期刊文献+

博舒替尼合成路线图解

Graphical synthetic routes of bosutinib
原文传递
导出
摘要 目的:通过分析已有的博舒替尼合成方法,找到适合工业化生产的路线。方法:对博舒替尼的合成路线进行总结。结果与结论:路线4原料易得,条件温和,总收率较高,更加适于工业化生产。 Objective: To review the existing synthetic routes of bosutinib, and find the suitable route for industrialization. Methods : We summarized the various synthetic processes of bosutinib. Results and Conclusion : The route 4, with the moderate reaction conditions and a high total yield, shows more favorable in manufacturing scale.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第4期462-464,共3页 Chinese Journal of New Drugs
关键词 博舒替尼 逆合成分析 喹啉环 合成路线图解 bosutinib retrosynthetic analysis quinoline ring graphical synthetic routes
  • 相关文献

参考文献1

二级参考文献4

  • 1US Food and Drug Administration. FDA approves new orphan drug for chronic myelogenous leukemia I EB/OL 1. [- 2012 - 09 - 04 ]. http ://www. fda. gov/ NewsEvents/Newsroom/PressAnnouncements/ ucm318160, htm.
  • 2BOS:,II D,ZALESKA M,ARDNT K,et al.4-I (2,4- Dichltxo-5-methoxyphenyl ) an o ] -6- aikoxy-3-quinoline- carbonitdles for the treatment of ischemic injury:WO, 2004075898 [ P]. 2304 -10-09.
  • 3ADIL I D,SMITHA S K,MANSOOR N S,et al. Phase I study of bosutinib ,a Src/Abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors[ J ]. Clin Cancer Res,2012,18(4) :1092 -1100.
  • 4GUNHILD K, PHILIPPE S, TIM H, et al. Bosutinib: a dual Src/Abl kinase inhibitor for the treatment of chronic myeloid leukemia [ J ]. Expert Rev Hematol, 2009,2 (5) :489 - 497.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部